BridgeMD
Compares treatment options for Atrial Fibrillation, Persistent
Official title Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
ClinicalTrials.gov ID: NCT06207383
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate two treatment strategies in patients with chronic atrial fibrillation and heart failure, who are eligible for atrial fibrillation ablation. Patients will be randomized to either atrial fibrillation ablation or to implantation of a pacemaker with conduction system pacing followed by atrioventricular node ablation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- (i) Persistent AF with symptomatic HF despite medical therapy, considered to be suitable for AF ablation, with at most one previous PVI procedure.
- (ii) At least one prior hospital admission, or emergency room / HF clinic visit for HF in the past 2 years, with NT-pro-BNP \> 1000 pg/ml or BNP \>...
- (iii) Previous or current rate or rhythm control drug therapy. (iv) Age \> 60 years
You likely can't join if
- (i) NYHA Class IV and systolic blood pressure ≤80 mmHg despite optimized therapy.
- (ii) Life expectancy \< 2 years. (iii) Need for major surgical intervention. (iv) Myocardial infarction, stroke or PCI within the previous 3 months...
- (vi) Participation in another controlled trial. (vii) Inability to sign and informed consent form.
The study team makes the final eligibility decision.
Where it's taking place
- Graz, Austria
- Antwerp, Belgium
- Sofia, Bulgaria
- Prague, Czechia
- Helsinki, Finland
- Rouen, France
- Leipzig, Germany
- Budapest, Hungary
- Bologna, Italy
- Maastricht, Netherlands
- Krakow, Poland
- Madrid, Spain
- Geneva, Canton of Geneva, Switzerland
- Basel, Switzerland
- Bern, Switzerland
- Zurich, Switzerland
- London, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Graz, Austria; Antwerp, Belgium; Sofia, Bulgaria; Prague, Czechia; Helsinki, Finland; Rouen, France and 11 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.